Effects of sirolimus upon endothelial thrombotic function of human umbilical vein endothelial cells

National Medical Journal of China

Volumn 91, Issue 18, 2011, Pages 1281-1284

  Nie, Xiao Min ^a   Zhou, Yu Jie ^a   Li, Yan Fang ^a   Xie, Ying ^a   Su, Li Xiao ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Drug eluting stents; Endothelial cells; Sirolimus; Thrombosis

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RAPAMYCIN; THROMBOMODULIN; THROMBOPLASTIN; NOS3 PROTEIN, HUMAN;

ANALYZER; ARTICLE; CELL FUNCTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIAL THROMBOTIC FUNCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; CELL CULTURE; DRUG ELUTING STENT; METABOLISM; VASCULAR ENDOTHELIUM;

CELLS, CULTURED; DRUG-ELUTING STENTS; ENDOTHELIUM, VASCULAR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NITRIC OXIDE SYNTHASE TYPE III; PLASMINOGEN ACTIVATOR INHIBITOR 1; SIROLIMUS; THROMBOMODULIN; THROMBOPLASTIN;

EID: 84869811087     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2011.18.016     Document Type: Article

References (17)

1. 2010, 90: 2112-2113.
2. 2006, 86: 1106.
3. Beusekom HM, Sorop O, van den Heuvel M, et al. Endothelial function rather than endothelial restoration is altered in paclitaxel-as compared to bare metal-, sirolimus and tacrolimus-eluting stents. Eurolntervention, 2010, 6: 117-125.
4. Joner M, Nakazawa G, Finn AV, et al. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol, 2008, 52: 333-342.
5. 2006, 86: 1706-1709.
6. Cutler C, Kim HT, Ayanian S, et al. Prediction of veno-occlusive disease using biomarkers of endothelial injury. Biol Blood Marrow Transplant, 2010, 16: 1180-1185.
7. Bruns CJ, Koehl GE, Guba M, et al. Rapamycin induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic therapy against pancreatic cancer. Clin Cancer Res, 2004, 10: 2109-2119.
8. Lin ZY, Kumar A, SenBanerjee S, et al. Kruppel-Like Factor 2 (KLF2) regulates endothelial thrombotic function. Cir Res, 2005, 96: e48-e56.
9. Steffel J, Latini RA, Akhmedov A, et al. Rapamycin, but not FK-506, increases endothelial tissue factor expression: implications for drug-eluting stent design. Circulation, 2005, 112: 2002-2011.
10. Muldowney JA, Stringham JR, Levy SE, et al. Antiproliferative agents alter vascular plasminogen activator inhibitor-1 expression: a potential prothrombotic mechanism of drug-eluting stents. Arterioscler Thromb Vasc Biol, 2007, 27: 400-406.
11. Cyongyosi M, Strehblow C, Sperker W, et al. Platelet activation and high tissue factor level predict acute stent thrombosis in pig coronary arteries: prothrombogenic response of drug-eluting or bare stent implantation within the first 24 hours. Thromb Haemost, 2006, 96: 202-209.
12. Jiao JA, Kelly AB, Marzec UM, et al. Inhibition of acute vascular thrombosis in chimpanzees by an anti-human tissue factor antibody targeting the factor X binding site. Thromb Haemost, 2010, 103: 224-233.
13. Eren M, Painter CA, Atkinson JB, et al. Age-dependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human plasminogen activator inhibitor-1. Circulation, 2002, 106: 491-496.
14. Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med, 2003, 349: 1315-1323.
15. Klugherz BD, Llanos G, Lieuallen W, et al. Twenty-eight-day efficacy and pharmacokinetics of the sirolimus-eluting stent. Coron Artery Dis, 2002, 13: 183-188.
16. Schwartz RS, Chronos NA, Virmani R, et al.Preclinical restenosis models and drug-eluting stents: still important, still much to learn. J Am Coll Cardiol, 2004, 44: 1373-1385.
17. Grewe PH, Deneke T, Machraoui A, et al. Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen. J Am Coll Cardiol, 2000, 35: 157-163.